INVO Bioscience (INVO) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free INVO Stock Alerts $1.00 -0.07 (-6.54%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media INVO Bioscience Short Interest DataCurrent Short Volume33,000 sharesPrevious Short Volume17,600 sharesChange Vs. Previous Month+87.50%Dollar Volume Sold Short$33,000.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares2,740,000 sharesFloat Size2,720,000 sharesShort Percent of Float1.21%Today's Trading Volume510,272 sharesAverage Trading Volume616,214 sharesToday's Volume Vs. Average83% Short Selling INVO Bioscience ? Sign up to receive the latest short interest report for INVO Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINVO Short Interest Over TimeINVO Days to Cover Over TimeINVO Percentage of Float Shorted Over Time Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! INVO Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202433,000 shares $33,000.00 +87.5%1.2%0 $1.00 4/15/202417,600 shares $13,499.20 +45.5%0.7%0 $0.77 3/31/202412,100 shares $13,673.00 +10.0%0.5%0.4 $1.13 3/15/202411,000 shares $11,330.00 -1.8%0.5%0.4 $1.03 2/29/202411,200 shares $12,880.00 -24.3%0.5%0.2 $1.15 2/15/202414,800 shares $12,551.88 -32.4%0.6%0.1 $0.85 Get the Latest News and Ratings for INVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. 1/31/202421,900 shares $21,900.00 +2.3%0.9%0 $1.00 1/15/202421,400 shares $22,470.00 -51.0%0.9%0 $1.05 12/31/202343,700 shares $58,995.00 -24.4%1.8%0 $1.35 12/15/202357,800 shares $71,094.00 -70.6%N/A0 $1.23 11/30/2023196,700 shares $367,829.00 -80.3%N/A0.1 $1.87 11/15/2023997,200 shares $1.84 million +245.1%N/A0.3 $1.85 10/31/2023289,000 shares $375,700.00 +397.4%N/A0.2 $1.30 10/15/202358,100 shares $39,827.55 -52.7%N/A0 $0.69 9/30/2023122,700 shares $96,957.54 +740.4%N/A0.6 $0.79 9/15/202314,600 shares $15,184.00 -13.6%N/A0.1 $1.04 8/31/202316,900 shares $25,519.00 -86.7%N/A0.1 $1.51 8/15/2023127,400 shares $181,545.00 +182.5%N/A0.5 $1.43 7/31/202345,100 shares $223,696.00 -84.5%N/A0.2 $4.96 7/15/2023290,600 shares $51,145.60 -38.8%N/A0.2 $0.18 6/30/2023474,800 shares $95,054.96 +363.2%3.2%0.4 $0.20 6/15/2023102,500 shares $17,404.50 +94.5%0.8%0.1 $0.17 5/31/202352,700 shares $13,417.42 -28.6%0.4%0.1 $0.25 5/15/202373,800 shares $26,095.68 No Change0.6%0.4 $0.35 10/31/202259,200 shares $68,080.00 -17.2%N/A2.4 $1.15 10/15/202271,500 shares $88,660.00 +3.6%N/A2.8 $1.24 9/30/202269,000 shares $73,140.00 +102.9%N/A2.6 $1.06 9/15/202234,000 shares $49,640.00 +38.8%N/A1 $1.46 8/31/202224,500 shares $23,716.00 -63.6%N/A0.8 $0.97 8/15/202267,300 shares $76,049.00 +3.9%N/A1.5 $1.13 7/31/202264,800 shares $64,152.00 +19.8%N/A1.4 $0.99 7/15/202254,100 shares $51,936.00 -30.7%N/A1.1 $0.96 6/30/202278,100 shares $49,976.19 +65.5%N/A1.5 $0.64 6/15/202247,200 shares $41,819.20 -42.1%N/A0.9 $0.89 5/31/202281,500 shares $79,829.25 +13.5%N/A1.5 $0.98 5/15/202271,800 shares $101,956.00 +22.5%N/A1.9 $1.42 4/30/202258,600 shares $88,486.00 -34.0%N/A1.7 $1.51 4/15/202288,800 shares $166,944.00 -1.0%N/A2.1 $1.88 3/31/202289,700 shares $236,808.00 +27.1%N/A2.2 $2.64 3/15/202270,600 shares $154,614.00 +2.3%N/A1.6 $2.19A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. INVO Short Interest - Frequently Asked Questions What is INVO Bioscience's current short interest? Short interest is the volume of INVO Bioscience shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 33,000 shares of INVO short. 1.21% of INVO Bioscience's shares are currently sold short. Learn More on INVO Bioscience's current short interest. What is a good short interest percentage for INVO Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.21% of INVO Bioscience's floating shares are currently sold short. Is INVO Bioscience's short interest increasing or decreasing? INVO Bioscience saw a increase in short interest in April. As of April 30th, there was short interest totaling 33,000 shares, an increase of 87.5% from the previous total of 17,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is INVO Bioscience's float size? INVO Bioscience currently has issued a total of 2,740,000 shares. Some of INVO Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. INVO Bioscience currently has a public float of 2,720,000 shares. How does INVO Bioscience's short interest compare to its competitors? 1.21% of INVO Bioscience's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to INVO Bioscience: Quoin Pharmaceuticals, Ltd. (0.26%), Assure Holdings Corp. (0.84%), Sharps Technology, Inc. (1.27%), Tenon Medical, Inc. (0.66%), Aethlon Medical, Inc. (3.04%), ReShape Lifesciences Inc. (1.68%), Dynatronics Co. (2.09%), Venus Concept Inc. (0.56%), Bluejay Diagnostics, Inc. (3.91%), Nemaura Medical Inc. (0.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short INVO Bioscience stock? Short selling INVO is an investing strategy that aims to generate trading profit from INVO Bioscience as its price is falling. INVO shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against INVO Bioscience? A short squeeze for INVO Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INVO, which in turn drives the price of the stock up even further. How often is INVO Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INVO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: QNRX Short Interest IONM Short Interest STSS Short Interest TNON Short Interest AEMD Short Interest RSLS Short Interest DYNT Short Interest VERO Short Interest BJDX Short Interest NMRD Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INVO) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity